Europhar
0465.065.411 · rovalta.com · 24/09/2026
Europhar
Overview
What does Europhar do?
Europhar is a Public limited company incorporated in 1999. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Genappe. It employs on average 16,1 ETP workers (FTE).
1470 Genappe · WallonieSee on map
Joint committees (1)
- 313
Trend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||||
| Gross margin | 1,6 M € | +3.7% | 1,5 M € | +20.6% | 1,2 M € | +22.2% | 1 M € | +5.2% | 972 k € | -5.7% | 1 M € | -3.6% | 1,1 M € | +36.0% | 786,2 k € | -13.8% | 911,6 k € | +37.6% | 662,5 k € | +31.8% | 502,7 k € | -10.5% | 561,7 k € | +10.1% | 510,1 k € | +10.3% | 462,6 k € | +6.9% | 432,6 k € | +7.9% | 400,9 k € | +113% | 188,3 k € | +95.3% | 96,4 k € | +320% | 23 k € | -78.9% | 109 k € |
| EBITDA | 660,3 k € | +17.2% | 563,2 k € | +47.3% | 382,4 k € | +106% | 186 k € | +64.4% | 113,1 k € | -56.4% | 259,4 k € | +16.2% | 223,2 k € | +27.0% | 175,7 k € | -42.8% | 307,1 k € | +141% | 127,7 k € | -4.5% | 133,8 k € | -44.4% | 240,5 k € | -0.6% | 242 k € | +12.5% | 215,1 k € | -16.6% | 257,9 k € | +9.8% | 234,9 k € | +195% | 79,6 k € | +176% | 28,8 k € | +195% | -30,3 k € | -202% | 29,6 k € |
| Operating result | 408,4 k € | +8.9% | 375 k € | +82.7% | 205,3 k € | +970% | 19,2 k € | +133% | -57,4 k € | -165% | 88,7 k € | +9.2% | 81,2 k € | +2502% | 3,1 k € | -98.4% | 196,3 k € | +783% | 22,2 k € | -64.8% | 63,2 k € | -63.4% | 172,5 k € | +2.1% | 169 k € | +21.3% | 139,4 k € | -23.5% | 182,2 k € | +10.9% | 164,3 k € | +918% | 16,1 k € | +236% | -11,8 k € | +72.6% | -43,1 k € | -316% | 20 k € |
| Net result | 242,2 k € | +20.2% | 201,5 k € | +571% | 30 k € | +163% | -47,4 k € | +60.2% | -119 k € | +2.2% | -121,7 k € | -2.3% | -118,9 k € | +17.9% | -144,9 k € | -649% | 26,4 k € | +171% | -37,2 k € | -10779% | -342,2 € | -100% | 69,4 k € | -9.4% | 76,5 k € | +42.7% | 53,6 k € | -57.4% | 125,9 k € | +14.1% | 110,3 k € | +502% | -27,4 k € | -21.6% | -22,6 k € | +53.9% | -48,9 k € | -516% | 11,7 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||||
| Equity | 230,2 k € | +2023% | -12 k € | +94.4% | -213,5 k € | +12.3% | -243,5 k € | -24.2% | -196,1 k € | -154% | -77,1 k € | -273% | 44,6 k € | -72.7% | 163,5 k € | -39.6% | 270,9 k € | +10.8% | 244,6 k € | -13.2% | 281,8 k € | -0.1% | 282,1 k € | +32.6% | 212,8 k € | +56.2% | 136,2 k € | +64.9% | 82,6 k € | +291% | -43,3 k € | +71.8% | -153,6 k € | -21.7% | -126,2 k € | -21.8% | -103,6 k € | -89.4% | -54,7 k € |
| Total assets | 3,5 M € | +4.8% | 3,3 M € | -2.9% | 3,4 M € | -1.8% | 3,5 M € | -11.9% | 4 M € | +1.9% | 3,9 M € | -5.2% | 4,1 M € | -0.4% | 4,1 M € | +34.2% | 3,1 M € | -1.3% | 3,1 M € | +34.7% | 2,3 M € | -0.3% | 2,3 M € | +2.2% | 2,3 M € | +82.8% | 1,2 M € | +12.4% | 1,1 M € | +3.0% | 1,1 M € | +2.2% | 1 M € | +134% | 446,3 k € | +159% | 172,2 k € | -13.5% | 199,2 k € |
| Cash | 242,1 k € | +118% | 111 k € | – | 8,1 k € | -97.6% | 336,4 k € | +470% | 59 k € | +61.9% | 36,4 k € | -4.8% | 38,3 k € | +259% | 10,7 k € | -91.0% | 118,5 k € | +24.2% | 95,4 k € | -41.0% | 161,7 k € | +29.4% | 124,9 k € | +1.7% | 122,8 k € | +329% | 28,6 k € | +51.6% | 18,9 k € | +0.9% | 18,7 k € | +227% | 5,7 k € | +83.8% | 3,1 k € | +563% | 469,6 € | ||
| Debts | 3,2 M € | -2.4% | 3,3 M € | -8.7% | 3,6 M € | -2.7% | 3,7 M € | -10.1% | 4,1 M € | +5.1% | 3,9 M € | -2.6% | 4 M € | +2.6% | 3,9 M € | +41.4% | 2,8 M € | -2.4% | 2,9 M € | +41.4% | 2 M € | -0.3% | 2 M € | -1.0% | 2 M € | +86.1% | 1,1 M € | +8.2% | 1 M € | -8.5% | 1,1 M € | -7.3% | 1,2 M € | +110% | 572,4 k € | +108% | 275,8 k € | +8.6% | 253,9 k € |
| Other | |||||||||||||||||||||||||||||||||||||||
| Workforce | 16,1 ETP | -1.2% | 16,3 ETP | +8.7% | 15,0 ETP | -2.0% | 15,3 ETP | +7.0% | 14,3 ETP | -5.9% | 15,2 ETP | +6.3% | 14,3 ETP | +19.2% | 12,0 ETP | – | 11,2 ETP | +27.3% | 8,8 ETP | +31.3% | 6,7 ETP | +48.9% | 4,5 ETP | 0.0% | 4,5 ETP | +25.0% | 3,6 ETP | 0.0% | 3,6 ETP | +20.0% | 3,0 ETP | +200% | 1,0 ETP | 0.0% | 1,0 ETP | -50.0% | 2,0 ETP | ||
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 3 active · 29 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
PHARMACIE DES PAGODES● Active | 0875.872.386 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/08/2026 | 29/08/2025 | 16/12/2024 | 08/11/2023 | 05/09/2022 | 19/10/2021 |
| General meeting | 19/08/2026 | 28/08/2025 | 14/11/2024 | 30/10/2023 | 30/06/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
21 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 19/08/2026 | 31/08/2026 | French | |
| Abridged model | 31/12/2024 | 28/08/2025 | 29/08/2025 | French | |
| Abridged model | 31/12/2023 | 14/11/2024 | 16/12/2024 | French | |
| Abridged model | 31/12/2022 | 30/10/2023 | 08/11/2023 | French | |
| Abridged model | 31/12/2021 | 30/06/2022 | 05/09/2022 | French | |
| Abridged model | 31/12/2020 | 30/06/2021 | 19/10/2021 | French | |
| Abridged model | 31/12/2019 | 31/12/2020 | 06/01/2021 | French | |
| Abridged model | 31/12/2018 | 21/05/2019 | 14/08/2019 | French | |
| Abridged model | 31/12/2017 | 15/05/2018 | 31/07/2018 | French | |
| Abridged model | 31/12/2016 | 16/05/2017 | 14/08/2017 | French | |
| Abridged model | 31/12/2015 | 17/05/2016 | 27/06/2016 | French | |
| Abridged model | 31/12/2014 | 19/05/2015 | 30/06/2015 | French | |
| Abridged modelCorrection | 31/12/2013 | 20/05/2014 | 11/08/2014 | French | |
| Abridged model | 31/12/2013 | 20/05/2014 | 31/07/2014 | French | |
| Abridged model | 31/12/2012 | 21/05/2013 | 30/07/2013 | French | |
| Abridged model | 31/12/2011 | 26/05/2012 | 20/07/2012 | French | |
| Abridged model | 31/12/2010 | 27/05/2011 | 12/07/2011 | French | |
| Abridged model | 31/12/2009 | 28/05/2010 | 31/05/2010 | French | |
| Abridged model | 31/12/2008 | 29/05/2009 | 16/09/2009 | French | |
| Abridged model | 31/12/2007 | 20/05/2008 | 08/07/2008 | French | |
| Abridged model | 31/12/2006 | 29/05/2007 | 30/07/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 3 active · 29 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Other22/09/2026—
- Other09/01/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - OBJET
- Mandates22/05/2023SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
- Restructuring24/01/2019CAPITAL, ACTIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Mandates10/01/2019DEMISSIONS, NOMINATIONS
- Restructuring27/06/2018RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Mandates07/06/2016DEMISSIONS, NOMINATIONS
- Mandates14/01/2015DEMISSIONS, NOMINATIONS
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025242,2 k €↑
- 2024Annual accounts 2024201,5 k €↑
- 2023Annual accounts 202330 k €↑
- 2022Annual accounts 2022-47,4 k €↑
- 2021Annual accounts 2021-119 k €↑
- 2020Annual accounts 2020-121,7 k €↓
- 2019Annual accounts 2019-118,9 k €↑
- 2018Annual accounts 2018-144,9 k €↓
- 2017Annual accounts 201726,4 k €↑
- 2016Annual accounts 2016-37,2 k €↓
- 2015Annual accounts 2015-342,2 €↓
- 2014Annual accounts 201469,4 k €↓
- 2013Annual accounts 201376,5 k €↑
- 2012Annual accounts 201253,6 k €↓
- 2011Annual accounts 2011125,9 k €↑
- 2010Annual accounts 2010110,3 k €↑
- 2009Annual accounts 2009-27,4 k €↓
- 2008Annual accounts 2008-22,6 k €↑
- 2007Annual accounts 2007-48,9 k €↓
- 2006Annual accounts 200611,7 k €
- 08/01/1999IncorporationPublic limited company